At Simulations Plus, we stand with the Black community against racial discrimination, violence, and injustice. We are committed to diversity and inclusion in our workplace and re-doubling our efforts in support of these objectives within our organization and in the community we serve.

Full Statement

Welcome to the Simulations Plus Family!

Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe

Read Press Release

DILIsym Simulations Support the Liver Safety of Ubrogepant

Dr. Paul B. Watkins and Dr. Jeff Woodhead discuss the DILIsym analysis of the latest publication in Toxicological Sciences!

Register Here

Simulations Plus Offers Rapid Response COVID-19 Research Initiative

Simulations Plus announced today the launch of its COVID-19 ACT Program to provide expedited, expert consulting assistance in coronavirus research.

Read More

FDA Master Reviewer To Lead Regulatory Strategies Team

Our goal is to help our clients minimize or eliminate the questions posed by regulatory reviews while decreasing the cost and time it takes to develop detailed reports.

Learn More

Modeling & Simulation

To improve the productivity of science-based research & development enterprises by delivering innovative modeling and simulation software and insightful consulting services.

Learn More

Pop PK/PD Data Analysis

Providing strategic pharmacology and pharmacometric consulting services, PK/PD model development with NONMEM, clinical trial simulations, exposure-response evaluations, dose justification strategies and related data management services.

Learn More

Pharma Safety & Efficacy

Ensuring the safety of drug therapies by leveraging our expertise in the areas of drug-induced liver injury, metabolic diseases, and modeling and simulation.

Learn More

POP Modeling & Simulation

Lixoft products are designed to save the time and energy of pharmacometricians and biostatisticianby bringing breakthrough advances to the modeling & simulation community in user-friendly tools.

Learn More

Model-Based Drug Development To Make Better Data-Driven Decisions

Our reputation as thought leaders in the areas of ADMET property prediction, PBPK modeling, pharmacometrics, and quantitative systems pharmacology/toxicology is earned through the success our clients have found through their relationship with us. We have the talent and 20+ years experience to translate science into user-friendly software and provide expert consulting supporting drug discovery, clinical development research, and regulatory submissions.

Ready to try it yourself?

Sign up for a FREE evaluation or
schedule a call with one of our consultants!

Questions? Call +1 661.723.7723

Ready to try it yourself?

Sign up for a FREE evaluation in 60 seconds or
schedule a call with one of our consultants!

Questions? Call +1 661.723.7723

Ready to try it yourself?

Sign up for a FREE evaluation in 60 seconds or
schedule a call with one of our consultants!

Questions? Call +1 661.723.7723